Three patients had atypical carcinoids, one with multipleendocrineneoplasia type 1 syndrome.
2
Pituitary adenomas represent one of the key features of multipleendocrineneoplasia type 1.
3
She was diagnosed as having multipleendocrineneoplasia type 1 with gastrinoma and liver metastases.
4
At diagnosis, all patients were checked for the presence of multipleendocrineneoplasia type I syndrome.
5
One patient presented with multipleendocrineneoplasia syndrome.
6
The multipleendocrineneoplasia syndromes are an association of tumours of 2 or more endocrine glands.
7
Eight patients had sporadic NETs, and 1 had multipleendocrineneoplasia type 1 syndrome.
8
Medullary thyroid carcinoma is the most common cause of death among patients with multipleendocrineneoplasia (MEN) 2.
9
The diagnosis of medullary thyroid carcinoma by biochemical and genetic testing is possible in families with multipleendocrineneoplasia type 2.
10
Combined biochemical and genetic screening for multipleendocrineneoplasia type 2 is important and effective for the cure of medullary thyroid carcinoma.
11
All were symptomatic at presentation except one who had multiglandular involvement as a part of multipleendocrineneoplasia (MEN)-I screening.
12
Of the 43 pheochromocytomas, 16 were neoplasms inherited in the setting of multipleendocrineneoplasia type 2A.
13
Early diagnosis of multipleendocrineneoplasia (MEN) syndromes is critical for optimal clinical outcomes; before the MEN syndromes can be diagnosed, they must be suspected.
14
An association between blood type O and neuroendocrine tumors in multipleendocrineneoplasia type 1 (MEN1) patients was recently suggested.
15
Linkage between seven loci on chromosome 19 and multipleendocrineneoplasia type 2a (MEN2A) was examined in a single large Swedish pedigree.
16
Objective and design: Genetic screening in multipleendocrineneoplasia type 2 (MEN 2) has led to specific management guidelines based on genotype-phenotype analysis.